PMID: 6106735Sep 13, 1980Paper

Pneumococcal vaccine and otitis media

Lancet
P H MäkeläP Karma

Abstract

After an acute attack of otitis media 827 children aged 3 months to 6 years were assigned randomly to receive either 14-valent pneumococcal polysaccharide vaccine or a control vaccine (Haemophilus influenzae type b capsular polysaccharide). In children older than 6 months serum antibody responses to most of the vaccine polysaccharides were satisfactory. The response to type 6A was poor. Correspondingly, no clinical protection was seen below 6 months of age or against otitis media caused by group 6 pneumococci. Among the children more than 6 months old, the first 6 months after vaccination saw significantly (p < 0.001) fewer attacks caused by the pneumococal types represented in the vaccine (group 6 excepted) in those who received the pneumococcal vaccine than in those who received the control vaccine. Protection against type 19F was statistically significant (p < 0.01). The overall protective efficacy was 58%--somewhat better in children older than 2 years than in those younger. Previous attacks of otitis caused by pneumococci did not influence the protective efficacy of the vaccine.

References

Mar 1, 1976·The Annals of Otology, Rhinology, and Laryngology·V M HowieJ L Sloyer
Jan 1, 1978·Proceedings of the Society for Experimental Biology and Medicine·J M BorgoñoM R Hilleman
Jul 5, 1979·The New England Journal of Medicine·V I AhonkhaiG Schiffman
Dec 1, 1979·Annals of Internal Medicine·D J WinstonR P Gale
Sep 1, 1979·The Annals of Otology, Rhinology & Laryngology. Supplement·I Rapin
Jul 1, 1976·Hospital Practice·J O Klein
Oct 1, 1969·The Journal of Pediatrics·R C BrownleeH P Jackson
May 1, 1980·The Annals of Otology, Rhinology & Laryngology. Supplement·P KarmaP H Mäkelä
May 1, 1980·The Annals of Otology, Rhinology & Laryngology. Supplement·D W TeeleB A Rosner

❮ Previous
Next ❯

Citations

Mar 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·O RuuskanenM Leinonen
Jul 1, 1983·Indian Journal of Pediatrics·A Kumar
Jun 1, 1995·International Journal of Pediatric Otorhinolaryngology·P H KarmaB Rynnel-Dagöö
Jun 7, 2002·International Journal of Pediatric Otorhinolaryngology·Ingeborg J DhoogeGer T Rijkers
Aug 1, 1984·The Journal of Hygiene·R M Robins-BrowneH J Koornhof
Jul 18, 2002·Scandinavian Journal of Immunology·T Wuorimaa, H Käyhty
Jun 14, 1984·The New England Journal of Medicine·H PeltolaP H Mäkelä
Feb 15, 2001·The New England Journal of Medicine·J EskolaUNKNOWN Finnish Otitis Media Study Group
Feb 1, 1996·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M NermesB Björksten
Aug 1, 1992·Journal of Clinical Pharmacy and Therapeutics·N Bahal, M C Nahata
Jun 9, 1998·Annals of the New York Academy of Sciences·G S Giebink
Dec 1, 1980·Archives of Disease in Childhood·H P Lambert
Sep 29, 2004·Journal of Clinical Pathology·Q Zhang, A Finn
Feb 1, 1996·Annals of Medicine·T Heikkinen, O Ruuskanen
Jan 1, 1985·Acta paediatrica Scandinavica·L HammarströmC I Smith
Aug 17, 2005·Infectious Disease Clinics of North America·Tuomas JarttiOlli Ruuskanen
Mar 1, 1983·Pediatric Annals·S I Pelton, P Whitley
Aug 1, 1990·The Annals of Otology, Rhinology, and Laryngology·K PrellnerJ Heldrup
May 1, 1984·Clinical Pediatrics·H Peltola, M Virtanen
Jul 14, 2005·Scandinavian Journal of Infectious Diseases·Gunnar TomassonKarl G Kristinsson
May 20, 1999·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·G S Giebink
Apr 23, 2002·Pediatric Annals·Barry M Gray
May 15, 2002·The Pediatric Infectious Disease Journal·Anu SoininenHelena Käyhty
Apr 17, 2001·The Pediatric Infectious Disease Journal·T WuorimaaH Käyhty
Aug 10, 1999·The Pediatric Infectious Disease Journal·F GhaffarG H McCracken
Apr 27, 2000·The Pediatric Infectious Disease Journal·J Eskola
May 23, 2000·The Pediatric Infectious Disease Journal·J Eskola, T Kilpi
Jun 16, 2004·European Journal of Pediatrics·Heikki PeltolaHeinz-Josef Schmitt
Jun 12, 2003·The Pediatric Infectious Disease Journal·Masja StraetemansGerhard A Zielhuis
Oct 1, 1986·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology·K PrellnerK Offenbartl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.